Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Fong

Showing results (631-640 of 641) with videos related to

Pageof 65
Sort By:
Cell Metabolism|January 26, 2010
Regulation of energy homeostasis by bombesin receptor subtype-3: selective receptor agonists for the treatment of obesityXiao-Ming Guan, Howard Chen, Peter H Dobbelaar, et al.
The Lancet Regional Health. Western Pacific|September 25, 2025
Pathogen distribution and antimicrobial resistance among neonatal bloodstream infections in Southeast Asia: results from NeoSEAP, a multicentre retrospective studyBenjamin F R Dickson, Michelle Harrison, Maria Esterlita T Villanueva-Uy, et al.
Bioorganic & Medicinal Chemistry Letters|March 9, 2010
Discovery of a spiroindane based compound as a potent, selective, orally bioavailable melanocortin subtype-4 receptor agonistShuwen He, Zhixiong Ye, Peter H Dobbelaar, et al.
Bioorganic & Medicinal Chemistry Letters|July 6, 2010
Optimization of privileged structures for selective and potent melanocortin subtype-4 receptor ligandsQingmei Hong, Raman K Bakshi, James Dellureficio, et al.
Cell Metabolism|January 8, 2008
The acyclic CB1R inverse agonist taranabant mediates weight loss by increasing energy expenditure and decreasing caloric intakeCarol Addy, Hamish Wright, Koen Van Laere, et al.
Cell Reports. Medicine|March 25, 2026
Early-stage multi-cancer detection through a plasma extracellular vesicle protein signatureRichard J Lobb, Quan Zhou, David Fielding, et al.
Respiratory Investigation|August 5, 2019
Summary of the Japanese Respiratory Society statement for the treatment of lung cancer with comorbid interstitial pneumoniaTakashi Ogura, Nagio Takigawa, Keisuke Tomii, et al.
Lancet (London, England)|February 25, 2021
Improving lung health in low-income and middle-income countries: from challenges to solutionsJamilah Meghji, Kevin Mortimer, Alvar Agusti, et al.
Gut|February 8, 2024
Faecal microbial transfer and complex carbohydrates mediate protection against COPDKurtis F Budden, Shakti D Shukla, Kate L Bowerman, et al.
Anesthesia and Analgesia|March 14, 2018
Implication of Major Adverse Postoperative Events and Myocardial Injury on Disability and Survival: A Planned Subanalysis of the ENIGMA-II TrialW Scott Beattie, Duminda N Wijeysundera, Matthew T V Chan, et al.
Pageof 65

Showing results (631-640 of 641) with videos related to

Sort By:
Pageof 65
Cell Metabolism|January 26, 2010
Regulation of energy homeostasis by bombesin receptor subtype-3: selective receptor agonists for the treatment of obesityXiao-Ming Guan, Howard Chen, Peter H Dobbelaar, et al.
The Lancet Regional Health. Western Pacific|September 25, 2025
Pathogen distribution and antimicrobial resistance among neonatal bloodstream infections in Southeast Asia: results from NeoSEAP, a multicentre retrospective studyBenjamin F R Dickson, Michelle Harrison, Maria Esterlita T Villanueva-Uy, et al.
Bioorganic & Medicinal Chemistry Letters|March 9, 2010
Discovery of a spiroindane based compound as a potent, selective, orally bioavailable melanocortin subtype-4 receptor agonistShuwen He, Zhixiong Ye, Peter H Dobbelaar, et al.
Bioorganic & Medicinal Chemistry Letters|July 6, 2010
Optimization of privileged structures for selective and potent melanocortin subtype-4 receptor ligandsQingmei Hong, Raman K Bakshi, James Dellureficio, et al.
Cell Metabolism|January 8, 2008
The acyclic CB1R inverse agonist taranabant mediates weight loss by increasing energy expenditure and decreasing caloric intakeCarol Addy, Hamish Wright, Koen Van Laere, et al.
Cell Reports. Medicine|March 25, 2026
Early-stage multi-cancer detection through a plasma extracellular vesicle protein signatureRichard J Lobb, Quan Zhou, David Fielding, et al.
Respiratory Investigation|August 5, 2019
Summary of the Japanese Respiratory Society statement for the treatment of lung cancer with comorbid interstitial pneumoniaTakashi Ogura, Nagio Takigawa, Keisuke Tomii, et al.
Lancet (London, England)|February 25, 2021
Improving lung health in low-income and middle-income countries: from challenges to solutionsJamilah Meghji, Kevin Mortimer, Alvar Agusti, et al.
Gut|February 8, 2024
Faecal microbial transfer and complex carbohydrates mediate protection against COPDKurtis F Budden, Shakti D Shukla, Kate L Bowerman, et al.
Anesthesia and Analgesia|March 14, 2018
Implication of Major Adverse Postoperative Events and Myocardial Injury on Disability and Survival: A Planned Subanalysis of the ENIGMA-II TrialW Scott Beattie, Duminda N Wijeysundera, Matthew T V Chan, et al.
Pageof 65